Identification of de novo synthesized and relatively older proteins

Accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes

Abdul Jaleel, Gregory C. Henderson, Benjamin J. Madden, Katherine A. Klaus, Dawn M. Morse, Srinivas Gopala, K Sreekumaran Nair

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

OBJECTIVE - The accumulation of old and damaged proteins likely contributes to complications of diabetes, but currently no methodology is available to measure the relative age of a specific protein alongside assessment of posttranslational modifications (PTM). To accomplish our goal of studying the impact of insulin deficiency and hyperglycemia in type 1 diabetes upon accumulation of old damaged isoforms of plasma apolipoprotein A-1 (ApoA-1), we sought to develop a novel methodology, which is reported here and can also be applied to other specific proteins. RESEARCH DESIGN AND METHODS - To label newly synthesized proteins, [ring- 13C 6]phenylalanine was intravenously infused for 8 h in type 1 diabetic participants (n = 7) during both insulin treatment and 8 h of insulin deprivation and in nondiabetic participants (n = 7). ApoA-1 isoforms were purified by two-dimensional gel electrophoresis (2DGE) and assessment of protein identity, PTM, and [ring- 13C 6]phenylalanine isotopic enrichment (IE) was performed by tandem mass spectrometry. RESULTS - Five isoforms of plasma ApoA-1 were identified by 2DGE including ApoA-1 precursor (pro-ApoA-1) that contained the relatively highest IE, whereas the older forms contained higher degrees of damage (carbonylation, deamidation) and far less IE. In type 1 diabetes, the relative ratio of IE of [ring- 13C 6]phenylalanine in an older isoform versus pro-ApoA-1 was higher during insulin deprivation, indicating that de novo synthesized pro-ApoA-1 more rapidly accumulated damage, converting to mature ApoA-1. CONCLUSIONS - We developed a mass spectrometry-based methodology to identify the relative age of protein isoforms. The results demonstrated accelerated oxidative damage to plasma ApoA-1, thus offering a potential mechanism underlying the impact of poor glycemic control in type 1 diabetic patients that affects a patient's risk for vascular disease.

Original languageEnglish (US)
Pages (from-to)2366-2374
Number of pages9
JournalDiabetes
Volume59
Issue number10
DOIs
StatePublished - Oct 2010

Fingerprint

Apolipoprotein A-I
Type 1 Diabetes Mellitus
Protein Isoforms
Proteins
Phenylalanine
Insulin
Post Translational Protein Processing
Electrophoresis, Gel, Two-Dimensional
Diabetes Complications
Tandem Mass Spectrometry
Vascular Diseases
Hyperglycemia
Mass Spectrometry
Research Design

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Identification of de novo synthesized and relatively older proteins : Accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes. / Jaleel, Abdul; Henderson, Gregory C.; Madden, Benjamin J.; Klaus, Katherine A.; Morse, Dawn M.; Gopala, Srinivas; Nair, K Sreekumaran.

In: Diabetes, Vol. 59, No. 10, 10.2010, p. 2366-2374.

Research output: Contribution to journalArticle

Jaleel, Abdul ; Henderson, Gregory C. ; Madden, Benjamin J. ; Klaus, Katherine A. ; Morse, Dawn M. ; Gopala, Srinivas ; Nair, K Sreekumaran. / Identification of de novo synthesized and relatively older proteins : Accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes. In: Diabetes. 2010 ; Vol. 59, No. 10. pp. 2366-2374.
@article{558e4aae4de048c38151cacf3d1649c4,
title = "Identification of de novo synthesized and relatively older proteins: Accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes",
abstract = "OBJECTIVE - The accumulation of old and damaged proteins likely contributes to complications of diabetes, but currently no methodology is available to measure the relative age of a specific protein alongside assessment of posttranslational modifications (PTM). To accomplish our goal of studying the impact of insulin deficiency and hyperglycemia in type 1 diabetes upon accumulation of old damaged isoforms of plasma apolipoprotein A-1 (ApoA-1), we sought to develop a novel methodology, which is reported here and can also be applied to other specific proteins. RESEARCH DESIGN AND METHODS - To label newly synthesized proteins, [ring- 13C 6]phenylalanine was intravenously infused for 8 h in type 1 diabetic participants (n = 7) during both insulin treatment and 8 h of insulin deprivation and in nondiabetic participants (n = 7). ApoA-1 isoforms were purified by two-dimensional gel electrophoresis (2DGE) and assessment of protein identity, PTM, and [ring- 13C 6]phenylalanine isotopic enrichment (IE) was performed by tandem mass spectrometry. RESULTS - Five isoforms of plasma ApoA-1 were identified by 2DGE including ApoA-1 precursor (pro-ApoA-1) that contained the relatively highest IE, whereas the older forms contained higher degrees of damage (carbonylation, deamidation) and far less IE. In type 1 diabetes, the relative ratio of IE of [ring- 13C 6]phenylalanine in an older isoform versus pro-ApoA-1 was higher during insulin deprivation, indicating that de novo synthesized pro-ApoA-1 more rapidly accumulated damage, converting to mature ApoA-1. CONCLUSIONS - We developed a mass spectrometry-based methodology to identify the relative age of protein isoforms. The results demonstrated accelerated oxidative damage to plasma ApoA-1, thus offering a potential mechanism underlying the impact of poor glycemic control in type 1 diabetic patients that affects a patient's risk for vascular disease.",
author = "Abdul Jaleel and Henderson, {Gregory C.} and Madden, {Benjamin J.} and Klaus, {Katherine A.} and Morse, {Dawn M.} and Srinivas Gopala and Nair, {K Sreekumaran}",
year = "2010",
month = "10",
doi = "10.2337/db10-0371",
language = "English (US)",
volume = "59",
pages = "2366--2374",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "10",

}

TY - JOUR

T1 - Identification of de novo synthesized and relatively older proteins

T2 - Accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes

AU - Jaleel, Abdul

AU - Henderson, Gregory C.

AU - Madden, Benjamin J.

AU - Klaus, Katherine A.

AU - Morse, Dawn M.

AU - Gopala, Srinivas

AU - Nair, K Sreekumaran

PY - 2010/10

Y1 - 2010/10

N2 - OBJECTIVE - The accumulation of old and damaged proteins likely contributes to complications of diabetes, but currently no methodology is available to measure the relative age of a specific protein alongside assessment of posttranslational modifications (PTM). To accomplish our goal of studying the impact of insulin deficiency and hyperglycemia in type 1 diabetes upon accumulation of old damaged isoforms of plasma apolipoprotein A-1 (ApoA-1), we sought to develop a novel methodology, which is reported here and can also be applied to other specific proteins. RESEARCH DESIGN AND METHODS - To label newly synthesized proteins, [ring- 13C 6]phenylalanine was intravenously infused for 8 h in type 1 diabetic participants (n = 7) during both insulin treatment and 8 h of insulin deprivation and in nondiabetic participants (n = 7). ApoA-1 isoforms were purified by two-dimensional gel electrophoresis (2DGE) and assessment of protein identity, PTM, and [ring- 13C 6]phenylalanine isotopic enrichment (IE) was performed by tandem mass spectrometry. RESULTS - Five isoforms of plasma ApoA-1 were identified by 2DGE including ApoA-1 precursor (pro-ApoA-1) that contained the relatively highest IE, whereas the older forms contained higher degrees of damage (carbonylation, deamidation) and far less IE. In type 1 diabetes, the relative ratio of IE of [ring- 13C 6]phenylalanine in an older isoform versus pro-ApoA-1 was higher during insulin deprivation, indicating that de novo synthesized pro-ApoA-1 more rapidly accumulated damage, converting to mature ApoA-1. CONCLUSIONS - We developed a mass spectrometry-based methodology to identify the relative age of protein isoforms. The results demonstrated accelerated oxidative damage to plasma ApoA-1, thus offering a potential mechanism underlying the impact of poor glycemic control in type 1 diabetic patients that affects a patient's risk for vascular disease.

AB - OBJECTIVE - The accumulation of old and damaged proteins likely contributes to complications of diabetes, but currently no methodology is available to measure the relative age of a specific protein alongside assessment of posttranslational modifications (PTM). To accomplish our goal of studying the impact of insulin deficiency and hyperglycemia in type 1 diabetes upon accumulation of old damaged isoforms of plasma apolipoprotein A-1 (ApoA-1), we sought to develop a novel methodology, which is reported here and can also be applied to other specific proteins. RESEARCH DESIGN AND METHODS - To label newly synthesized proteins, [ring- 13C 6]phenylalanine was intravenously infused for 8 h in type 1 diabetic participants (n = 7) during both insulin treatment and 8 h of insulin deprivation and in nondiabetic participants (n = 7). ApoA-1 isoforms were purified by two-dimensional gel electrophoresis (2DGE) and assessment of protein identity, PTM, and [ring- 13C 6]phenylalanine isotopic enrichment (IE) was performed by tandem mass spectrometry. RESULTS - Five isoforms of plasma ApoA-1 were identified by 2DGE including ApoA-1 precursor (pro-ApoA-1) that contained the relatively highest IE, whereas the older forms contained higher degrees of damage (carbonylation, deamidation) and far less IE. In type 1 diabetes, the relative ratio of IE of [ring- 13C 6]phenylalanine in an older isoform versus pro-ApoA-1 was higher during insulin deprivation, indicating that de novo synthesized pro-ApoA-1 more rapidly accumulated damage, converting to mature ApoA-1. CONCLUSIONS - We developed a mass spectrometry-based methodology to identify the relative age of protein isoforms. The results demonstrated accelerated oxidative damage to plasma ApoA-1, thus offering a potential mechanism underlying the impact of poor glycemic control in type 1 diabetic patients that affects a patient's risk for vascular disease.

UR - http://www.scopus.com/inward/record.url?scp=77957598060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957598060&partnerID=8YFLogxK

U2 - 10.2337/db10-0371

DO - 10.2337/db10-0371

M3 - Article

VL - 59

SP - 2366

EP - 2374

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 10

ER -